ADIL

Adial Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website adialpharma.com
Employees(FY) 16
ISIN US00688A2050

Performance

-6.06%

1W

-30.8%

1M

+34.78%

3M

-24.02%

6M

-16.67%

YTD

-81.44%

1Y

Profile

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Advanced Technical Analysis

Technical Analysis of ADIL 2024-05-10

Overview:

In analyzing the technical indicators for ADIL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming trading days.

Trend In...

See more ...

Recent News & Updates

2024-05-14 21:54
ADIL Stock Earnings: Adial Pharmaceuticals Misses EPS for Q1 2024(Investorplace)
2024-05-14 20:30
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-04-21 22:00
EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent(Yahoo Finance)
2024-04-21 20:30
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office(Globenewswire)
2024-04-09 23:53
Why Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today?(Investorplace)
2024-04-09 20:30
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder(Globenewswire)
2024-04-01 20:30
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update(Globenewswire)
2024-03-01 06:00
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds(Yahoo Finance)
2024-02-27 20:30
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office(Globenewswire)
2024-02-14 20:00
Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20(Accesswire)
2024-02-12 20:15
Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office(Globenewswire)
2024-01-17 19:30
Adial Announces Appointment of Tony Goodman as Chief Operating Officer(Globenewswire)
2023-12-19 20:00
Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate(Globenewswire)
2023-11-29 03:05
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement(Globenewswire)
2023-11-14 04:02
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update(Globenewswire)
2023-10-30 20:30
Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss New Aspects in Substance Use Treatment at The Annual International Society of Addiction Medicine Conference(Globenewswire)
2023-10-30 00:00
All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy(Yahoo Finance)
2023-10-24 20:00
Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar(Globenewswire)
2023-10-24 04:30
Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules(Globenewswire)
2023-10-19 20:00
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules(Globenewswire)
2023-10-19 00:00
EXCLUSIVE: Adial Pharma Announces Key Patent To Combine Genetic Diagnostic With Lead Drug For Alcohol Addiction(Yahoo Finance)
2023-10-19 00:00
Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th(Accesswire)
2023-10-18 22:30
Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence(Globenewswire)
2023-10-17 20:00
Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award(Globenewswire)
2023-09-27 19:00
Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder(Globenewswire)
2023-09-04 20:30
Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference(Yahoo Finance)
2023-08-27 20:30
Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism(Yahoo Finance)
2023-08-22 20:30
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements(Yahoo Finance)
2023-08-20 20:30
Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update(Yahoo Finance)
2023-08-03 20:30
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaqs Minimum Bid Price Requirement and Reduce the Public Float(Yahoo Finance)

Page 1 of 4

previousnext